These findings, that Zbtb32-/- CD8+ T cells are refractory to clonal exhaustion in the presence of persistent antigen stimulation, raises the interesting possibility that manipulation of ZBTB32 activity may be useful in the context of cancer immunotherapy. Here, ZBTB32 is linked to cancer.